ArticleBMC urology2026
Comparing the clinical accuracy of urine exfoliated cell examination and fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma.
Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundTo compare the effectiveness and clinical accuracy of fluorescence in situ hybridization (FISH) and urine exfoliated cytology in the evaluation of upper urinary tract urothelial cell carcinoma (UTUC).
methods60 patients with suspected UUT-UC admitted to our hospital from May 2021 to May 2023 were selected. All patients underwent FISH and urine exfoliated cytology, and a ureteroscopy pathological biopsy was performed. Using pathological biopsy results as the “gold standard”, we analyzed the compliance rate of FISH and urine exfoliated cytology to evaluate UTUC.
resultsAmong 60 patients with suspected UTUC, 52 cases were confirmed positive by pathological biopsy, and 8 cases were negative. The positive detection rate of FISH was 90.38%, which was higher than 71.15% of urine exfoliated cytology (P < 0.05). The coincidence rate of urine exfoliated cytology in assessing high-grade UTUC tumors was 76.67%, and the discrepancy rate was 23.33%; the coincidence rate in assessing low-grade tumors was 63.64%, and the discrepancy rate was 36.36%. The coincidence rate of FISH in assessing high-grade UTUC tumors was 93.33%, and the discrepancy rate was 6.67%; the coincidence rate in assessing low-grade tumors was 86.36%, and the discrepancy rate was 13.64%.
conclusionCompared with urine exfoliated cytology, FISH demonstrated higher diagnostic accuracy for the detection of UTUC and greater accuracy in UTUC classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.